These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 2272176)
21. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648 [TBL] [Abstract][Full Text] [Related]
22. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
23. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Tefferi A; Thiele J; Vardiman JW Cancer; 2009 Sep; 115(17):3842-7. PubMed ID: 19472396 [TBL] [Abstract][Full Text] [Related]
24. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications. Panani AD Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090 [TBL] [Abstract][Full Text] [Related]
25. The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview. Tefferi A Mayo Clin Proc; 1998 Dec; 73(12):1177-84. PubMed ID: 9868417 [TBL] [Abstract][Full Text] [Related]
27. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients. Thiele J; Simon KG; Fischer R; Zankovich R Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544 [TBL] [Abstract][Full Text] [Related]
28. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation]. Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211 [TBL] [Abstract][Full Text] [Related]
29. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia]. González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395 [TBL] [Abstract][Full Text] [Related]
30. Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Dickstein JI; Vardiman JW Am J Clin Pathol; 1993 Apr; 99(4):513-25. PubMed ID: 8475918 [TBL] [Abstract][Full Text] [Related]
31. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification. Kvasnicka HM; Thiele J Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877 [TBL] [Abstract][Full Text] [Related]
35. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression. Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986 [TBL] [Abstract][Full Text] [Related]
36. Evidence from molecular genetic and cytogenetic analyses that bone marrow histopathology is reliable in the diagnosis of chronic myeloproliferative disorders. Werner M; Kaloutsi V; Kausche F; Buhr T; Georgii A Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(4):199-204. PubMed ID: 8099457 [TBL] [Abstract][Full Text] [Related]
37. [Hematologic abnormalities in a patient with chronic myelogenous leukemia with advanced myelofibrosis were improved by G-CSF]. Hiruma K; Saitoh H; Someya K; Kashimura M Rinsho Ketsueki; 1994 Feb; 35(2):135-41. PubMed ID: 7511182 [TBL] [Abstract][Full Text] [Related]
38. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes]. Bock O Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608 [TBL] [Abstract][Full Text] [Related]
39. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia. Nakata Y Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600 [TBL] [Abstract][Full Text] [Related]